Because of the unacceptably high rate of adverse patient events, including deaths, linked to the point-of-care (POC) use of glucose meters within hospitals, there is a recognized need for more accuracy and better performance standards for POC glucose testing in hospitals, particularly in intensive care settings.
StatStrip is designed specifically to measure and correct for clinical interferences that can be present in critically ill patients.
Proven safety and accuracy
Use of any other meter with critically ill patients is considered off label in the U.S. by the FDA and high complexity testing under CLIA
Use of any other glucose meter with critically ill patients is off label
StatStrip is FDA and Health Canada cleared and CLIA waived for use throughout all hospital and all professional healthcare settings including critical care. Use of any other glucose meter with critically ill patients is considered off-label in the U.S. by the FDA and high complexity testing under CLIA.
The personnel testing requirements for off-label use are very demanding and limit who can perform testing. In addition, a hospital must obtain patient consent to perform off-label testing.
The most extensively studied and proven glucose measurement technology
In addition to the studies submitted to the FDA, 168 other independent studies over the last eight years—including 53 critical care studies—have found no clinically significant interferences for StatStrip. This is a statement that no other glucose meter manufacturer can make. Download a bibliography of publications here
For more information click here
Loading...
Women's Health Community Supported by Hologic
Comprehensive information on women’s health issues and management, management and personalisation.
Enterprise Imaging Community
Advanced and scalable radiology solutions that can help improve care coordination, increase speed and facilitate accurate clinical decisions.
Decision Support Community Supported by Siemens Healthineers
Leading the way in highlighting useful and efficient decision support tools for improved patient outcomes.
Sepsis Community Supported by Abionic
Addressing the latest developments in sepsis and providing clinically useful information for diagnosis and treatment of patients.
What Do We Know About XBB.1.5?
The XBB.1.5 variant is a new sub-variant of Omicron. It has been identified... Read more
Major Healthcare Impacts of COVID-19
“Health at a Glance: Europe 2022” outlines the impact of the pandemic... Read more
Ten High-Income Countries Report the Effects of COVID-19 Burnout on Primary Care Physicians
According to a new report from the Commonwealth Fund, the COVID-19 pandemic... Read more
JOIN OUR MANAGEMENT COMMUNITY